Charlie Lees Profile Banner
Charlie Lees Profile
Charlie Lees

@charlie_lees

18,383
Followers
2,776
Following
2,067
Media
8,455
Statuses

I write about inflammatory bowel disease providing inspiration, education and deep community. I am Professor of Gastroenterology and UKRIFLF. I also run a lot.

Sign up to Atomic IBD here
Joined May 2010
Don't wanna be here? Send us removal request.
Pinned Tweet
@charlie_lees
Charlie Lees
7 months
Advanced therapies for inflammatory bowel disease Fully updated • biologics in green • small molecules in red • biosimilars / generics in italics • late stage development in light grey Future timelines may not be fully accurate - will keep updating with further…
Tweet media one
28
77
283
@charlie_lees
Charlie Lees
4 years
Top 10 tips for people with #IBD during the #COVID19 coronavirus pandemic. Prepared by the UK IBD working group. Thanks to everyone for their input. Please RT and share. We want people to know what the latest advice is. @CrohnsColitisUK @BritSocGastro @ErikRVA @sandybcamera
26
264
426
@charlie_lees
Charlie Lees
3 years
1st dose of the Pfizer/BioNTech Covid-19 #vaccine 💉 today. Brilliant team led by Pauline at the Western General. I am recommending vaccination to all my patients with #Crohn ’s & #colitis . You can watch our live Q&A on #covid & IBD 👇 Peace ✌️& hope 🙏
Tweet media one
Tweet media two
16
51
417
@charlie_lees
Charlie Lees
2 years
Head to head studies in IBD - 🧵
Tweet media one
9
103
324
@charlie_lees
Charlie Lees
1 year
Drugs for UC in 2023: what, when and how?
Tweet media one
7
91
313
@charlie_lees
Charlie Lees
1 year
10 principles to guide the management of Crohn's disease
Tweet media one
9
78
304
@charlie_lees
Charlie Lees
5 years
I am absolutely thrilled to announce that I have been awarded a 7 year @UKRI_News Future Leaders Fellowship #UKRIFLF - This will allow the rapid expansion of my ambitious programme of research in #IBD ( #Crohn 's disease & #UC ).
Tweet media one
53
31
302
@charlie_lees
Charlie Lees
3 years
• I hope that virtual conferences are NOT the future • I wish I was in the USA right now at Digestive Diseases Week • I've been every year since 2004 • Want to know why I want to be there? Read on👇 📍Do you feel this too❓For the same or different reasons❓ #Ship30for30
Tweet media one
29
53
303
@charlie_lees
Charlie Lees
3 years
I have spent 18 years working in the IBD clinic - Tuesday mornings as a fellow & trainee (2003-9); Thursdays as a consultant (2010-present). This has given me a critical long-term perspective on the very nature of Crohn's disease & UC. Here are FIVE lessons on IBD care.
Tweet media one
18
67
284
@charlie_lees
Charlie Lees
1 year
10 important randomised clinical trials in IBD published in 2022 Thread featuring: • UPA for UC • RISA for CD • ABX464 in UC • Filgotinib for UC • Ozanimod for UC • ADA vs USTE in CD • FMT plus AID for UC • High-dose ADA in IBD
1
69
264
@charlie_lees
Charlie Lees
1 year
10 questions to ask your patients with IBD at every clinical interaction
Tweet media one
11
62
265
@charlie_lees
Charlie Lees
3 years
SEVEN (!) new molecules could enter the clinic for IBD within the next THREE years. These 7 new drug therapies include: • two S1P inhibitors in UC • three p19 inhibitors (Crohn's & UC) • two JAK1 selective inhibitors in UC Read on for a break down of what's coming soon [👇]
Tweet media one
10
80
259
@charlie_lees
Charlie Lees
2 years
Who gets IBD and why? A brief illustrated 🧵
Tweet media one
15
98
256
@charlie_lees
Charlie Lees
1 year
Top 12 papers on gut inflammation from 2022 These are the scientific / translational papers that had the biggest impact on me this year • Heavily focused on diet and the microbiome • High quality science papers from @Nature @ScienceMagazine and @CellCellPress
8
68
260
@charlie_lees
Charlie Lees
3 years
#WorldIBDday2021 - a time for hope & reflection • We must do more to raise awareness • But there is great cause for optimism • With brilliant minds & sufficient research funding • Treatments will begin to look more like cures #NoGoingBack #BreakTheSilence #ship30for30
Tweet media one
2
120
253
@charlie_lees
Charlie Lees
1 year
Drugs for UC in 2023 - part 2 Vedolizumab, ustekinumab and the new small molecules
Tweet media one
8
58
251
@charlie_lees
Charlie Lees
1 year
Drug therapy for Crohn's disease in 2023 - what, how and when?
Tweet media one
8
58
243
@charlie_lees
Charlie Lees
7 months
In 10 years time, a newly diagnosed IBD patient will have: • complete disease control >90% of patients • first medicine works >90% persistence • minimal / zero toxicity Completely normal quality of life Hospitalisations & surgeries <10% of patients Not a cure, but closer
19
24
242
@charlie_lees
Charlie Lees
1 year
Not all high calprotectins are indicative of active IBD. These are the other possible causes. If in doubt retest and / or scope.
Tweet media one
8
82
237
@charlie_lees
Charlie Lees
6 months
Twelve principles to guide therapy in Crohn's disease 1/ Crohn's disease is progressive With long-term, irreversible bowel damage, disability and poor quality of life the result. - - 2/ Diagnostic delay is associated with worse outcomes Ensure effective systems are in place…
10
59
214
@charlie_lees
Charlie Lees
5 months
After 2.5 years, today is Bea's last official day working in the Edinburgh IBD Unit. It is difficult to express here what an incredible impact she has made on the entire team in Edinburgh. Her hard work, dedication, passion and joy for the every day has impacted us all and…
Tweet media one
10
11
208
@charlie_lees
Charlie Lees
2 years
We have an effective toolkit to help many people living with IBD. When deployed early in the disease course we can achieve deep and sustained remission for many patients. The following strategy [👇] is not perfect, but is cost-effective and can be adopted widely. NEW thread 🧵
15
65
200
@charlie_lees
Charlie Lees
2 years
Treatment principles in Crohn's disease: a graphical thread 🧵 (n~28) There is lots covered here • impact of CD • early effective therapy • surgical trends • biosimilars • head to head studies • mucosal healing Follow along below👇
Tweet media one
12
69
198
@charlie_lees
Charlie Lees
3 years
Inflammatory bowel disease (IBD) • affects nearly 1% in the West • any age but mostly young people • cause: 🥗 🧬 🦠 • symptoms can be intrusive • treatment can be v effective • but doesn't always work • surgery & stoma often needed IBD is not IBS! #ship30for30
Tweet media one
5
64
192
@charlie_lees
Charlie Lees
2 years
Fermented foods merit proper investigation in Crohn’s disease & UC They perform better than high fibre diets in a randomised study @CellCellPress ⬇️ inflammatory cytokines ⬆️ microbial diversity Unexpected finding: demonstrates the importance of research to test assumptions
Tweet media one
6
48
190
@charlie_lees
Charlie Lees
1 year
Drug therapy for Crohn's disease in 2023 - part 2
Tweet media one
9
48
178
@charlie_lees
Charlie Lees
3 years
We now have clear guidance from JCVI on those patients eligible for a 3rd primary dose of COVID vaccine. This includes IBD patients on infliximab, adalimumab, ustekinumab, tofacitinib, prednisolone and some on high-dose aza/mp/mtx. Details here & below
Tweet media one
18
79
179
@charlie_lees
Charlie Lees
6 months
Crohn's disease is progressive: • strictures and fistulas • surgery and stomas • gut failure and TPN • disability & ↓ QoL There is an inflammatory window of opportunity • avoid diagnostic delay • treat (very) early And use effective therapies • biosimilar…
Tweet media one
7
37
177
@charlie_lees
Charlie Lees
5 years
PRESS RELEASE Our team have shown that 1 in 125 people in Edinburgh live with Crohn's or ulcerative colitis ... rates will exceed 1% within 10y. This replicates recent data from @gilkaplan in Canada. This is an urgent problem at a vast scale. 1/n
11
101
174
@charlie_lees
Charlie Lees
2 years
Initial thoughts from #DDW2022 taking a look at therapies for IBD - new molecules and controlled data on existing molecules #atomicIBD
19
63
174
@charlie_lees
Charlie Lees
4 years
Advice for people with #Crohn 's & #UC from the UK #IBD #COVID19 working group. Please report confirmed cases to #IOIBD Secure-IBD Registry Full guidance for UK IBD teams imminent via @BritSocGastro Stay safe & keep well
Tweet media one
8
110
170
@charlie_lees
Charlie Lees
7 months
Some initial thoughts post #UEGWeek2023 Risankizumab looks v good for Crohn's disease; impressive delta vs USTE across all primary and secondary endpoints • Lifting the therapeutic ceiling a little but hardly smashing through it • BUT ... multiple USTE biosimilars ready for…
3
41
170
@charlie_lees
Charlie Lees
6 months
My approach to Crohn's disease drug therapy Plenty of nuance in here - a UK perspective where cost is an important factor How does this change in your practice?
Tweet media one
13
33
165
@charlie_lees
Charlie Lees
1 year
Fatigue is a major issue for people living with IBD Sleep too - and they cannot be addressed in isolation
Tweet media one
11
35
164
@charlie_lees
Charlie Lees
2 years
What is inflammatory bowel disease? There appears to still be confusion, so let's clear things up: • IBD is not the same as IBS • IBD consists of Crohn's and UC • IBD is lifelong with no known cure • IBD requires treatment to prevent bowel damage IBD and IBS often co-exist
Tweet media one
6
46
163
@charlie_lees
Charlie Lees
2 years
Crohn's disease and ulcerative colitis These inflammatory bowel diseases can have a marked impact on a person's life
Tweet media one
10
61
156
@charlie_lees
Charlie Lees
1 year
When should you get your calprotectin checked as an IBD patient? These are 8 key time points to look out for.
Tweet media one
6
34
157
@charlie_lees
Charlie Lees
5 months
How I approach every clinical interaction with an IBD patient. “What is on your agenda to discuss today?” Bowel symptoms • stool frequency, consistency, blood, urgency, incontinence, pain Systemic symptoms • Nausea & vomiting, appetite, diet and weight, night sweats…
Tweet media one
4
36
157
@charlie_lees
Charlie Lees
2 years
Treatment landscape for Crohn's disease and UC. • A timeline based on EMA approval dates • A slide needing regular updates • New molecules and biosimiliars Good news for clinicians and patients. Let's discuss a little more ... 🧵
Tweet media one
4
45
159
@charlie_lees
Charlie Lees
1 year
10 new papers of interest about IBD - published in the last 2 weeks Thread featuring: • SPARE trial • NMA of zoster risk • IBD diagnostic delay • antibiotics & IBD risk • RWE of tofa and RISA • Monogenic IBD guidance • autoantibodies that antedate UC
3
42
156
@charlie_lees
Charlie Lees
6 months
My approach to therapy for UC at the end of 2023 Choice of first line therapy driven by • disease activity • cost of therapy  • demographics Many excellent therapies for first line use. Significant variation in practice at the national and international level.…
Tweet media one
3
33
158
@charlie_lees
Charlie Lees
3 years
Tens of millions of people across the world live with Crohn's disease and ulcerative colitis, but why? What causes inflammatory bowel disease? [NEW THREAD] Answered this KEY question will help us treat (cure) and ultimately prevent IBD.
Tweet media one
8
72
157
@charlie_lees
Charlie Lees
3 years
I've been thinking about the unmet need in IBD. • What is achievable now? • Therapeutic pipeline is rich (hope) • We have hit a therapeutic ceiling (problem) • What else do patients need? • Prevention & cure = moonshot 👇[click below] to read; pls add comments #ship30for30
Tweet media one
12
31
154
@charlie_lees
Charlie Lees
2 years
10 unmet needs in Crohn’s disease and ulcerative colitis
Tweet media one
6
40
151
@charlie_lees
Charlie Lees
6 months
This morning I ran a thought experiment I asked which IBD advanced therapies you would keep if you were only allow three. My response and rationale is as follows: 1/ Infliximab I'm definitely taking an anti-TNF and infliximab is my drug of choice. • highly effective in…
19
25
146
@charlie_lees
Charlie Lees
6 months
In 2023 we have multiple effective agents approved for use in Crohn’s disease What are the pros and cons of each as first-line agents? Note 1: starting any one of these agents will usually be better than not starting any in moderate or severe Crohn's disease. Note 2: The best…
3
54
149
@charlie_lees
Charlie Lees
2 years
Introduction to advanced therapies in IBD My talk to the surgeons @ACPGBI today @eicc 🧵 covering: • therapeutic targets • treatment strategies • therapeutic ceiling • early effective therapies in Crohn's • the pros and cons of anti-TNF • new small molecules for UC
Tweet media one
4
54
148
@charlie_lees
Charlie Lees
1 year
Each day I am publishing an atomic essay on IBD A master thread 🧵 of essays from the last 2 weeks covering: • Drugs for UC in 2023 • Drugs for CD in 2023 • Positioning of drugs • Managing IBD on a budget • The flare clinic model • And more ... By Atomic IBD
5
40
142
@charlie_lees
Charlie Lees
1 year
Drugs for Crohn's disease in 2023 - part 3 - positioning
Tweet media one
5
47
145
@charlie_lees
Charlie Lees
3 years
Some days the clinic is hard • the drugs aren't working • the disease has progressed • the psychological toll is heavy Today was one of those days when IBD was hard 👇[click below] for my reflections from the clinic #ship30for30
Tweet media one
12
28
143
@charlie_lees
Charlie Lees
2 years
The rate of progress in IBD is staggeringly fast. This should bring hope to patients, their families and the clinical teams working hard to help them. We have much to do, but very many reasons to be hopeful. On this 13th #worldIBDday I share my annual letter of hope
Tweet media one
10
38
143
@charlie_lees
Charlie Lees
4 years
While there may be an increased risk of complications with #covid19 for people taking immunosuppressants, please do not stop taking them now. Stopping them risks a disease flare. The biggest risk for infection is active #IBD (of moderate to severe activity). @CrohnsColitisUK
@CrohnsColitisUK
Crohn's & Colitis UK
4 years
We have received a high number of calls/messages from people with #Crohns or #Colitis who are worried about the #Coronavirus (aka #COVID19 ). We will continue to update our website as we receive more information.
16
86
146
4
100
138
@charlie_lees
Charlie Lees
6 months
We now have three key head-to-head studies in IBD All have important implications for clinical practice Which would you most like to see next? 👇👇👇 - - VARSITY • Vedo versus ADA in UC • Vedo shows superiority - - SEAVUE • USTE versus ADA in bionaive Crohn's •…
8
35
140
@charlie_lees
Charlie Lees
7 months
SEQUENCE phase 3b RCT Clear evidence of superiority for risankizumab over ustekinumab in Crohn’s disease Endoscopic remission at week 48 double with RZB (31.8%) vs UST (16.2%) Hugely important data - for more results including study design keep reading👇
Tweet media one
1
32
139
@charlie_lees
Charlie Lees
1 year
10 reasons to get your faecal calprotectin checked and know the result as an IBD patient
Tweet media one
10
29
138
@charlie_lees
Charlie Lees
5 months
The impact of IBD on a person's life is not just physical Physical aspects • diarrhoea, urgency, blood in stool and pain • loss of appetite and weight loss • night sweats and fevers • nausea and vomiting • joint pains, eye problems, skin rashes and mouth ulcers…
Tweet media one
6
34
139
@charlie_lees
Charlie Lees
2 years
2 new IBD therapies in 3 papers and 1 editorial in @TheLancet today • Upadacitinib in ulcerative colitis • Risankizumab induction in Crohn's disease • Risankizumab maintenance in Crohn's disease Exciting molecules coming to the clinic later this year I will unpack all soon
Tweet media one
4
36
137
@charlie_lees
Charlie Lees
2 months
The most invigorating ECCO congress in recent years I’m hunkering down in a central Stockholm hotel for the next 24 hours to write my thoughts for Atomic IBD
Tweet media one
8
3
135
@charlie_lees
Charlie Lees
3 years
Leaving the hospital after the Christmas Eve IBD clinic. I’m looking forward to a few quiet and restful days off. I hope everyone has the chance for a moment of peace. The Edinburgh sky is incredible tonight.
Tweet media one
7
4
133
@charlie_lees
Charlie Lees
1 year
“Cut the crap” to help earlier diagnosis of Crohn’s disease and ulcerative colitis. At Scottish Parliament for @CrohnsColitisUK
Tweet media one
2
12
132
@charlie_lees
Charlie Lees
3 years
Today I want to discuss DIET and IBD The most common question in the clinic is "Doctor, what should I EAT?" 👇 [click below] to read my thoughts • I'm interested to hear how you approach this • Look out for tomorrow when i'll discuss @PREdiCCt #ship30for30 #UKRIFLF
Tweet media one
12
29
131
@charlie_lees
Charlie Lees
1 month
Upadacitinib for Crohn's disease • data from Edinburgh and Exeter • n=93 with median 25w follow-up • effective in highly refractory cohort See 👇 for figures and link @FrontGastro_BMJ
Tweet media one
5
36
131
@charlie_lees
Charlie Lees
9 months
A full day of IBD clinic where there was no hiding from the unmet need our patients face • treatments that don’t work • unrelenting disease progression • substantial psychosocial morbidity A day when the current tools feel inadequate We work hard to find practical…
6
15
131
@charlie_lees
Charlie Lees
3 years
The impact of Crohn's disease and UC on a person's life can be devastating. With 1 in 125 of the population living with #IBD it is important we realise what they might be going through. It isn't just physical; here 👇 are just some of the ways IBD affects people.
Tweet media one
8
47
129
@charlie_lees
Charlie Lees
5 years
Why do I travel? To TEACH about IBD. To SHAKE UP old dogma. To use new DATA to promote EARLY appropriate treatment with EFFECTIVE drugs. To INSPIRE teams to RESEARCH & COLLABORATE. To provide HOPE to patients. IBD is a global disease; it has no respect for cultural boundaries.
Tweet media one
4
29
126
@charlie_lees
Charlie Lees
3 years
Starting May 15 I'll post an atomic essay & video every day for 30 days #ship30for30 #UKRIFLF I'm going to write about #IBD exploring • unanswered questions • unmet need • improving outcomes • environment, diet, the microbiome& genetics • digital health • & resilience
33
18
130
@charlie_lees
Charlie Lees
3 years
I have an important message for our entire global IBD community. A message to: • our patients • my fellow healthcare professionals • academics, clinician scientists, industry & biotech partners • patient organisations, charities & funding bodies It is a message of hope ✌️
Tweet media one
9
34
129
@charlie_lees
Charlie Lees
3 years
I've started to think about life for our patients post-pandemic. We face many challenges but I'm optimistic. Advances in drug development, genomics, digital health, AI & more. This is the start of a new series on Innovations in IBD & the story of the innovators. #ship30for30
Tweet media one
20
29
127
@charlie_lees
Charlie Lees
4 years
This is my talented and beautiful daughter Holly playing her pipes - every Thursday at 8pm outside our house. We are all in this together. Wish i'd swept the yard! Every week a different tune.
6
6
125
@charlie_lees
Charlie Lees
1 year
Twelve different drugs are available to treat UC in 2023. How do you choose the right drug for the right patient at the right time?
Tweet media one
3
28
126
@charlie_lees
Charlie Lees
20 days
The 1 in 100 living with IBD ...
7
25
125
@charlie_lees
Charlie Lees
1 year
An illustrated thread 🧵 on JAK inhibitors for IBD Game-changing small molecules that • work fast • work when TNF fails • don't need steroids to work Follow along as I outline the key themes 👇
Tweet media one
2
34
122
@charlie_lees
Charlie Lees
5 months
10 reasons to get your faecal calprotectin checked and know the result as an IBD patient Calprotectin is not a perfect test and we know it is fiddly to collect; but it is a very powerful tool to monitor levels of gut inflammation. 1. The goals of treatment in Crohn's disease…
6
31
119
@charlie_lees
Charlie Lees
18 days
Fatigue and IBD
12
19
122
@charlie_lees
Charlie Lees
2 years
A patient comes to the IBD clinic. I know him very well but I have not seen him for some time. He has had troublesome IBD for many years. Multiple admissions, several surgeries and lots of different medicines. But something is different ... 1/n
12
27
118
@charlie_lees
Charlie Lees
1 year
Excellent piece on Crohn’s disease and cricket in today’s @thetimes Mike Atherton (who has UC) writes sensitively and accurately about Jack Leach who has Crohn’s disease (and takes adalimumab). Great to see such a positive story @Athersmike @jackleach1991 @CrohnsColitisUK
Tweet media one
3
20
119
@charlie_lees
Charlie Lees
23 days
Atomic IBD Uncut - Episode One Something new • daily videos • one take, uncut • here and on YouTube Talking about IBD • therapies new and old • evolving IBD management • holistic care
10
17
123
@charlie_lees
Charlie Lees
2 years
Let's talk about equity of care in IBD Every person living with Crohn's disease or ulcerative colitis should have access to good care No matter geography, age, gender, ethnicity, social status, wealth This is an urgent issue for our global community
4
13
118
@charlie_lees
Charlie Lees
3 years
Looking for a simple guide for treating Crohn's disease? • Here is a set of principles • Should work with current effective therapies • The field is moving fast • This framework will help you integrate new data • And new therapies 👇[click below to read] #ship30for30
Tweet media one
13
30
118
@charlie_lees
Charlie Lees
3 years
Crohn's disease and ulcerative colitis can have a significant impact on a person's life. • physical symptoms • psychological aspects • long-term complications of disease • impact on everyday life With good medical care from an IBD team this can be minimised. #ship30for30
Tweet media one
9
19
118
@charlie_lees
Charlie Lees
1 year
All of this happened in IBD this month 👇 🧵 thread featuring: • VEGA pub • UPFs & Crohn's • ADA descalation • pharma news items • an amazing 5-ASA story • serological signatures & CD • IFX biosimilar multi-switching • a brilliant new website of IBD trials
2
41
116
@charlie_lees
Charlie Lees
6 years
ANNOUNCEMENT: I’m going to start a new series of patient education events across Scotland for people affected by IBD ... starting in Edinburgh early October. Are you keen to get involved or help out? Please get in touch. Aiming to make it fun, informative, educational & social.
19
52
115
@charlie_lees
Charlie Lees
1 year
Inflammatory bowel disease can have a profound impact on the individual. And we are seeing a global surge in unmet needs. In this illustrated thread we'll unravel the key challenges.
Tweet media one
6
44
114
@charlie_lees
Charlie Lees
2 months
Thiopurine monotherapy is essentially no more in the updated ECCO Crohn’s guidelines 👏👏👏
Tweet media one
8
31
112
@charlie_lees
Charlie Lees
5 years
Watch my #ECCO19 plenary talk on #PrecisionMedicine in #IBD in full here thanks to amazing webcast. Stratifying by disease biology to choose the right drug for the right patient.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
39
111
@charlie_lees
Charlie Lees
1 year
A simple guide to the workings of the Edinburgh IBD flare clinic
Tweet media one
11
15
109
@charlie_lees
Charlie Lees
4 years
Two fundamental principles in Crohn's disease: 1. Disease is progressive 2. Disconnect between symptoms & inflammation Treat inflammation early & effectively to stop disease progression. So important we made a video about it: @ErikRVA @CrohnsColitisUK
3
46
113
@charlie_lees
Charlie Lees
1 year
First wow moment #ECCO23 for me Vedolizumab highly effective in post-operative recurrence in Crohn’s disease (high-risk population) Practice changing data
0
18
111
@charlie_lees
Charlie Lees
3 years
FIVE simple ways to transform care in the IBD clinic today. • ASK about fatigue, mood and sleep • Enquire about diet • Be curious about IBD and impact on life • Think about medication adherence • Check calprotectin Moving close to holistic care. #ship30for30
Tweet media one
8
24
110
@charlie_lees
Charlie Lees
7 years
For #WorldIBDDay I've written a blog post. It's for everyone involved with #IBD It's important. Please read & share
Tweet media one
11
101
109
@charlie_lees
Charlie Lees
6 months
10 tips to improve outcomes for your IBD patients in 2023 1) ADOPT early effective therapy in Crohn’s disease This is best way to stop the disease from progressing. 2) Manage flares expediently in UC with advanced therapies Stopping flares quickly is good for patients and…
6
30
110
@charlie_lees
Charlie Lees
2 years
Upadacitinib meets key primary efficacy endpoints in Crohn's disease U-ENDURE: phase 3 RCT of upadacitinib maintenance in moderate to severely active Crohn's disease Data taken from Abbvie Press Release 11th May 2022
Tweet media one
2
20
110
@charlie_lees
Charlie Lees
2 years
It is a beautiful morning in Vienna @my_ueg #UEGWeek22 Have a wonderful day filled with great science, clinical updates and networking ✌️
Tweet media one
4
5
111
@charlie_lees
Charlie Lees
2 years
Anti-TNF drugs are highly effective and affordable therapies for Crohn’s disease and UC But they have 3 main problems: 1. They don’t work for everyone 2. They lose effectiveness over time 3. Subsequent therapies work less well
Tweet media one
11
17
110
@charlie_lees
Charlie Lees
4 years
➡️IBD and live in the UK? ➡️Please go to ➡️On-line risk tool generated by my brilliant friend @DrNickKennedy & @IBDRegistry & @CrohnsColitisUK ➡️It takes 5 minutes ➡️Based on the @BritSocGastro risk grid ➡️Secure & GDPR compliant ➡️Help us help you
9
83
111
@charlie_lees
Charlie Lees
1 year
From fatigue to food choices, inflammatory bowel disease can impact every aspect of a person's life. Learn more about the many ways this chronic disease affects daily life.
Tweet media one
9
32
109
@charlie_lees
Charlie Lees
1 year
Who else just loves Chicago for #DDW2023
Tweet media one
8
0
109
@charlie_lees
Charlie Lees
22 days
The PANTS-extension study out today @LancetGastroHep After 3 years of therapy only 1/3 IFX and 1/3 ADA patients are still on drug in remission • notable that proportion exiting due to drug failure higher with ADA versus IFX (remember this is NOT randomised h2h) Most…
Tweet media one
4
40
110
@charlie_lees
Charlie Lees
7 months
Requests for IBD sessions @my_ueg #UEGWeek next year • bring back proper poster session • put all post-hoc analysis of phase 3 RCTs in poster sessions • more oral presentations for academic work • don’t give abstract prizes to old professors presenting pharma data 🙏
7
20
108
@charlie_lees
Charlie Lees
6 years
Current therapies for #IBD with a few key pointers: - do not use 5ASA medicines in #Crohn 's disease - avoid excess use of steroids - azathioprine & MP are maintenance agents (so should not be used to induce remssion) - anti-TNF therapy works best when started early
8
38
105